| Natera, Inc. Common Stock | $38.7b | $339.50 | +2.7% | 1.5M | |
| Illumina Inc | $31.0b | $225.50 | +0.8% | 1.5M | |
| Labcorp Holdings Inc. | $25.0b | $337.69 | -0.5% | 579.8K | |
| QIAGEN N.V. | $8.7b | $43.73 | +4.5% | 3.7M | |
| BillionToOne, Inc. Class A Common Stock | $6.4b | $99.60 | +3.3% | 865.4K | |
| 10x Genomics, Inc. Class A Common Stock | $6.0b | $64.87 | +1.4% | 3.3M | |
| Veracyte, Inc. | $3.6b | $44.30 | +6.3% | 820.5K | |
| CareDx, Inc. | $2.3b | $51.30 | +7.0% | 1.6M | |
| NeoGenomics, Inc. | $2.0b | $16.88 | +2.3% | 712.7K | |
| GeneDx Holdings Corp. Class A Common Stock | $2.0b | $85.84 | +2.6% | 638.5K | |
| Personalis, Inc. Common Stock | $1.4b | $17.11 | +1.1% | 2.6M | |
| Azenta, Inc. | $1.3b | $33.22 | +1.0% | 870.9K | |
| Opko Health Inc. | $1.0b | $1.50 | +0.3% | 2.0M | |
| Mesa Laboratories Inc | $0.6b | $127.65 | +3.1% | 126.7K | |
| Fulgent Genetics, Inc. Common Stock | $470.0m | $19.93 | +2.8% | 155.0K | |
| Pacific Biosciences of California, Inc. | $441.1m | $1.50 | +18.8% | 15.3M | |
| Prenetics Global Limited Class A Ordinary Share | $314.8m | $23.10 | +6.0% | 507.6K | |
| Myriad Genetics Inc | $288.9m | $3.21 | +5.2% | 1.4M | |
| Insight Molecular Diagnostics Inc. Common Stock | $150.1m | $4.45 | +2.9% | 154.2K | |
| ALPS Group Inc Ordinary Share | $68.3m | $0.32 | 0.0% | 17.8K | |
| Quantum Cyber N.V. Ordinary Shares | $28.7m | $1.36 | +5.0% | 758.9K | |
| Bionano Genomics, Inc. Common Stock | $12.3m | $1.24 | +2.5% | 113.2K | |
| BioNexus Gene Lab Corp Common stock | $3.2m | $1.52 | 0.0% | 482 |